Get startedLog in
    Picture of Drugs Made In America Acquisition II logo

    DMIIU — Drugs Made In America Acquisition II Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsSpeculativeMid CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Drugs Made In America Acquisition II, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2024
    December 31st
    Period Length:12 M
    Source:PROSPECTUS
    Standards:
    USG
    Status:Final
    Net Income/Starting Line-0.152
    Changes in Working Capital-0.043
    Change in Prepaid Expenses
    Cash from Operating Activities-0.389
    Financing Cash Flow Items-0.074
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities0.423
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.017